Bellevue Group’s Amneal Pharmaceuticals AMRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-7,913	Closed	-$99.7K	–	156
2025 Q4	$99.7K	Hold	7,913	–	–	﹤0.01%	162
2025 Q3	$79.2K	Buy	+7,913	New	+$71K	﹤0.01%	144
2025 Q1	–	Sell	-100,414	Closed	-$795K	–	149
2024 Q4	$795K	Buy	100,414 +24,000	+31%	+$201K	0.02%	121
2024 Q3	$636K	Buy	76,414 +13,654	+22%	+$107K	0.01%	124
2024 Q2	$399K	Buy	62,760 +17,373	+38%	+$110K	0.01%	133
2024 Q1	$275K	Buy	45,387 +19,917	+78%	+$112K	﹤0.01%	147
2023 Q4	$155K	Buy	+25,470	New	+$113K	﹤0.01%	152
2020 Q1	–	Sell	-300,000	Closed	-$1.45M	–	217
2019 Q4	$1.45M	Buy	+300,000	New	+$1.04M	0.02%	144
2019 Q2	–	Sell	-100,000	Closed	-$1.42M	–	203
2019 Q1	$1.42M	Buy	100,000 +5,000	+5%	+$66.1K	0.08%	117
2018 Q4	$1.28M	Hold	95,000	–	–	0.08%	107
2018 Q3	$2.11M	Buy	95,000 +20,000	+27%	+$421K	0.13%	104
2018 Q2	$1.23M	Buy	+75,000	New	+$1.32M	0.1%	113